We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
We have a curated list of the most noteworthy news from all across the globe. With any subscription plan, you get access to exclusive articles that let you stay ahead of the curve.
The window to claim a portion of a $30 million settlement involving 23andMe is quickly closing.
In late 2023, 23andMe, a well-known genetic testing and biotech firm, experienced a “credential stuffing attack,” leading to a significant data breach. This incident prompted a class action lawsuit against the company. By September 2024, 23andMe revealed to Nexstar that it had reached a tentative $30 million settlement to resolve the lawsuit.
In a surprising turn of events, by March 2025, 23andMe filed for bankruptcy. Subsequently, a judge approved the acquisition of the company by TTAM Research Institute in July. TTAM is a California-based healthcare company with a focus on genetics, led by Anne Wojcicki, who co-founded 23andMe and is its former CEO.
